Why CLYM? Climb Bio, Inc. Analysis, Price & AI Insights | Whystock
CLYM
$12.29+0.84 (+7.34%)
Market OpenUpdated 1:09 PM EDT
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.